SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females

被引:0
|
作者
Li, Wei [1 ]
Liu, Wei [2 ]
Wang, Xiong [3 ]
Dou, Rui [1 ]
Zhu, Zunmin [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Inst Hematol, Henan Key Lab Stem Cell Differentiat & Modificat,P, Zhengzhou, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Publ Hlth, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
关键词
Tuberculosis; Polymorphism; Susceptibility; Chinese females; DRUG-INDUCED HEPATOTOXICITY; RIFAMPIN CONCENTRATIONS; RISK;
D O I
10.1007/s10528-023-10392-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate the role of SLCO1B1 polymorphisms in pulmonary tuberculosis (PTB) risk among Chinese patients. This study comprised 600 PTB patients (mean age: 37.43 & PLUSMN; 12.73 years) and 600 healthy controls (mean age: 37.39 & PLUSMN; 12.57 years) from a Chinese population. The SLCO1B1 rs2306283 and rs4149056 polymorphisms were detected using TaqMan genotyping assay. Chi-square (& chi;(2)) test was applied to calculate the Hardy-Weinberg Equilibrium (HWE) among controls. Logistic regression analysis was used to examine the odds ratio (OR) and 95% confidence interval (CI). After adjustment for age and gender, the frequency of rs4149056-C was significantly higher in PTB group (P = 0.017, OR = 1.375, 95% CI 1.058-1.786); meanwhile, rs4149056 was associated with increased PTB risk in dominant model (P = 0.015, OR = 1.424, 95% CI 1.072-1.892). The frequency and genotype of rs2306283 showed no significant difference between the two groups. In stratified analysis, rs2306283-GG showed notable susceptibility to PTB (P = 0.027, OR = 1.563, 95% CI 1.051-2.323 in recessive model) in females; rs4149056-C was also significantly higher in female PTB group (P = 0.039, OR = 1.741, 95% CI 1.028-2.948). Neither of rs2306283 and rs4149056 polymorphisms was associated with PTB risk in males. A haplotype analysis showed that patients carrying at least one SLCO1B1*15 haplotype had higher PTB risk (P = 0.004, OR = 1.527, 95% CI 1.145-2.034). SLCO1B1 polymorphisms are associated with the susceptibility to pulmonary tuberculosis in Chinese females.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 50 条
  • [41] SLCO1B1 variants associated with statin-induced myopathy
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (12): : 752 - 752
  • [42] Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia
    Hu, Miao
    Tomlinson, Brian
    ATHEROSCLEROSIS, 2012, 223 (02) : 427 - 432
  • [43] Effects of two functionally important SLCO1B1 gene polymorphisms on pharmacokinetics of atorvastatin
    Rajput, Tausif Ahmed
    Naveed, Abdul Khaliq
    Farooqi, Zia-Ur-Rehman
    Khan, Shakir
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (04) : 1363 - 1370
  • [44] Influence of SLCO1B1 Polymorphisms on the Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients
    Liu, Jiawen
    Zhu, Yongqian
    Zhang, Jiexiu
    Wei, Jintao
    Zheng, Ming
    Gui, Zeping
    Chen, Hao
    Sun, Li
    Han, Zhijian
    Tao, Jun
    Ju, Xiaobin
    Tan, Ruoyun
    Gu, Min
    Wang, Zijie
    CURRENT DRUG METABOLISM, 2023, 24 (02) : 114 - 123
  • [45] Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort
    Chen, Ru
    Wang, Jing
    Tang, Shaowen
    Zhang, Yuan
    Lv, Xiaozhen
    Wu, Shanshan
    Xia, Yinyin
    Deng, Peiyuan
    Ma, Yu
    Tu, Dehua
    Chen, Dafang
    Zhan, Siyan
    TUBERCULOSIS, 2015, 95 (01) : 68 - 74
  • [46] Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis
    Du, Yaming
    Wang, Sizheng
    Chen, Zhangyong
    Sun, Shusen
    Zhao, Zhigang
    Li, Xingang
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (34) : 4044 - 4050
  • [47] Influence of SLCO1B1 polymorphisms on lopinavir Ctrough in Serbian HIV/AIDS patients
    Dragovic, Gordana
    Dimitrijevic, Bozana
    Kusic, Jovana
    Soldatovic, Ivan
    Jevtovic, Djordje
    Olagunju, Adeniyi
    Owen, Andrew
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (07) : 1289 - 1295
  • [48] Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis
    Kim, Eun Sun
    Kwon, Byoung Soo
    Park, Jong Sun
    Chung, Jae-Yong
    Seo, Soo Hyun
    Park, Kyoung Un
    Song, Junghan
    Yoon, Seonghae
    Lee, Jae Ho
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (09) : 3492 - 3500
  • [49] Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians
    Sortica, Vinicius de A.
    Ojopi, Elida B.
    Genro, Julia P.
    Callegari-Jacques, Sidia
    Ribeiro-dos-Santos, Andrea
    de Moraes, Manoel Odorico
    Romano-Silva, Marco A.
    Pena, Sergio D. J.
    Suarez-Kurtz, Guilherme
    Hutz, Mara H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (05) : 460 - 468
  • [50] ULK1 polymorphisms confer susceptibility to pulmonary tuberculosis in a Chinese population
    Zhang, R-R.
    Liang, L.
    Chen, W-W.
    Wen, C.
    Wan, B-S.
    Luo, L-L.
    Zhao, Y-L.
    Chen, J.
    Yue, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (02) : 265 - +